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Abstract
Background: The aim of the present in vitro study was to investigate, in different genders, motor responses in
surgical colonic specimens from patients with rectal cancer undergoing and not undergoing chemotherapy with
capecitabine and radiotherapy.
Methods: This in vitro study was conducted from October 2015 to August 2017 at the Experimental Pharmacology
Laboratory at the National Institute “S. de Bellis” after collecting samples at the Department of Surgery. Segments of
sigmoid colon were obtained from 15 patients (Male (M)/Female (F) = 8/7; control group, CG) operated on for elective
colorectal resection for rectal cancer without obstruction and 14 patients (M/F = 7/7; study group, SG) operated on for
elective colorectal resection for rectal cancer who also received chemotherapy, based on capecitabine twice daily, and
radiotherapy. Isometric tension was measured on colonic circular muscle strips exposed to increasing carbachol or
histamine concentrations to obtain concentration-response curves. The motor responses to electrically evoked
stimulation were also investigated.
Results: In males, carbachol and histamine caused concentration-dependent contractions in the CG and SG.
An increased sensitivity and a higher response to carbachol and histamine were observed in SG than CG (P < 0.01). On
the contrary, in females, the response to carbachol was not significantly different in CG from the SG and the maximal
responses to carbachol were greater in CG than in SG (P < 0.001). The same applied to histamine for half-maximal
effective concentrations and maximal response in that they were not significantly different in CG from the SG.
Electrically evoked contractions were significantly more pronounced in males, especially in the SG (P < 0.05).
Conclusions: This preliminary in vitro study has shown gender differences in motor responses of colonic circular
muscle strips in patients who had received chemotherapy with capecitabine and radiotherapy.
Keywords: Chemotherapy, Radiotherapy, Capecitabine, Carbachol, Histamine, Nitrergic pathways, Motility, Human
colon, Gender
Background
The clinical manifestations associated with exposure to
chemotherapy and radiotherapy include diarrhea, ab-
dominal cramps and associated pain and, most fre-
quently, nausea and vomiting [1, 2]. Diarrhea involves
the interaction of motor activity and epithelial transport.
Mucositis is a key factor to be taken into account after
chemo- and radiotherapy [3].
Some authors have shown hypercontractility in gastric
fundic and duodenal muscle in rats after exposure to
Fluorouracil (5-FU) [4] while others have found in-
creased sensitivity to cholinergic stimulation in the duo-
denum and colon after whole-body irradiation in guinea
pigs [4, 5]. This increased responsiveness after irradi-
ation may be associated with colonic motor alterations
consisting in giant contractions in dogs and intestinal
migrating motor complexes disruption in rats [2, 6].
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The use of chemo- and radiotherapy disrupts the mu-
cosal barrier and represents a clinically significant risk
factor for local infections and sepsis [7]. Some studies
demonstrated significant enhancement in gastrointes-
tinal muscle contractility in response to carbachol dur-
ing infections and chronic inflammation [8, 9] and
increased sensitivity to histamine in inflammatory condi-
tions related to the release of leukotrienes that increase
histamine receptor numbers [10]. Furthermore, the in-
crease in gastrointestinal transit occurring during infec-
tion is mediated by endogenous tachykinins, modulated
by the activation of nitric oxide (NO) biosynthesis [11].
This tachykinergic component is most probably expressed
in elderly male patients per a gender-related difference in
receptor density of human colon [12].
Nevertheless, this increased in sensitivity to contractile
agonists is not universally observed. For instance, Sung
et al. showed a significant reduction in contractility to
carbachol in human stomach induced by cisplatin-based
chemotherapy [13]. Besides, the response to histamine
did not change in colitis in rats [14].
In 5-FU-induced oral mucositis, NO is also involved.
In fact, previous reports showed that proinflammatory
cytokines stimulate inducible NO synthase (iNOS)-der-
ived NO production [7]. The NO increase is in agree-
ment with studies reporting increased plasma nitric
oxide after oral administration of anticancer drugs in
rats and in disagreement with other studies reporting re-
duced expression of the inducible form of NOS in rats
receiving cisplatin and no change in neural NO synthase
(nNOS) expression in patients receiving chemotherapy
[13, 15, 16].
These discrepancies in contractile response to agonists,
carbachol and histamine, and NO production might be re-
lated to differences in species, intestinal tracts, duration of
chemotherapy and radiotherapy or length of time after
chemo-and radiotherapy as well as to gender.
Possible gender differences in the colonic response to
chemotherapy and radiotherapy have not been well char-
acterized. Therefore, the aim of the present in vitro
study was to investigate, in different genders, the re-
sponse to contracting agents (carbachol or histamine)
and electrical stimulation in surgical colonic specimens
from patients who had undergone standard chemother-
apy with capecitabine and radiotherapy, compared to pa-
tients who had not undergone chemo- and radiotherapy.
Methods
This in vitro study was conducted at the Experimental
Pharmacology Laboratory of The National Institute of
Gastroenterology “S. de Bellis” Castellana Grotte (BA) after
collecting samples at the Department of Surgery of the
same institute. The in vitro experiments were carried out
from October 2015 to August 2017. Segments of sigmoid
colon obtained from 15 patients (M/F = 8/7) operated on
for elective colorectal resection for rectal cancer served as a
control group (CG) and 14 patients (M/F = 7/7) operated
on for elective colorectal resection of rectal cancer who had
received neoadjuvant therapy, based on capecitabine
(Xeloda®, 825 mg/m2, Welwyn Garden City, United King-
dom), twice daily and one dose of radiotherapy (50.4 Gy in
28 fractions of 180 cGy/die) before surgery served as a
study group (SG). Patients were 15 men (8 CG, average age
73.4 ± 1.1 years; range 73–76 years and 7 SG, average age
73.3 ± 1.7 years; range 72–77 years) and 14 women (7 CG,
average age 74.3 ± 1.6 years; range 72–76 years and 7 SG,
average age 73.6 ± 1.3 years; range 72–78 years).
In all patients, preanaesthetic medication was intramus-
cular atropine (1 mg) and midazolam (5 mg). Anaesthesia
was induced by propofol (2.5 mg/kg) intravenously (i.v.)
and maintained with nitrous oxide/oxygen (N2O/O2) (1/2)
and sevoflurane (0.5–2%). Patients received norcuronium
(8 mg) i.v. during induction of anaesthesia.
Colonic strips were taken from a carcinoma-free area,
1–4 cm along the longitudinal axis.
Motility study in vitro
We used the same methods reported before [17]. In brief,
tissues were gently deprived of the mucosa and the muscle
segments were cut into strips (1.0 cm × 0.3 cm) trans-
versely (circular) to the axis of bowel. Circular muscle
strips were mounted in an organ bath (10 ml) containing
oxygenated Krebs solution, maintained at a temperature
of 37 °C and gassed with 5% carbon dioxide (CO2) in O2.
The composition of the Krebs solution was as follows: so-
dium chloride (NaCl) 115.5 mM; potassium chloride (KCl)
4.6 mM; calcium chloride (CaCl2) 2.5 mM; magnesium
chloride (MgCl2) 2.1 mM; sodium bicarbonate (NaHCO3)
21.9 mM; monosodium phosphate (NaHPO4) 1.2 mM; and
glucose 15.5 mM. Tissues were stored overnight at 4 °C
prior to use. Strips were tied with a silk ligature to an iso-
metric transducer (Force 100, N. S/N 77648, 77645, 77631,
ADInstruments Ltd., Unit B, Bishops Mews, Transport
Way, Oxford OX4 6HD, UNITED KINGDOM), and con-
tractions were recorded on a PowerLab/800 (Model
ML119 Serial 2265, ADInstruments Ltd., Unit B, Bishops
Mews, Transport Way, Oxford OX4 6HD, UNITED KING-
DOM) acquisition program. The muscle length was mea-
sured directly in the bath by using a caliper. After gentle,
repeated washings following by 1-h stabilization, tissues
were placed under a tension of 20–24 mN (in preliminary
tests it was shown that this baseline tension produces
the maximal response to 1 × 10−6M carbachol). After
equilibration, at least two comparable responses to car-
bachol were recorded before tissues were exposed to in-
creasing concentrations of carbachol, histamine or
electrical field stimulation (EFS). The motor response
to carbachol and histamine were investigated on
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circular strips obtained from male and female patients of
both groups. Strips were exposed to increasing concentra-
tions of carbachol (1 × 10−8M-1 × 10−6M, cumulatively)
and histamine (1 × 10−8M-1 × 10−6M, cumulatively) in
order to obtain concentration-response curves. The curves
were repeated after 60 min and some washing steps.
The motor responses to EFS were investigated on cir-
cular strips obtained from male and female patients of
both groups. EFS was performed with an electrical
stimulator type 215/T (Hugo Sachs Elektronik, March/
Freiburg, Germany) using two platinum wire electrodes
(15 mm in length and 5 mm in width) placed parallel to
the longitudinal axis of the strips. Electrodes were placed
4.5 mm from the strip. The duration of the train of elec-
trical pulses was always 10 s, and stimulation was per-
formed every 2 min (0.1–10 Hz, pulse duration 0.3 ms,
supramaximal strength: 20 V) [18, 19]. The current ap-
plied across the bath was monitored and the compliance
of voltage was also measured. The time interval between
each train of electrical pulses was always 60 min, be-
cause preliminary experiments indicated that this allows
to evoke reproducible control responses, apart from the
first response, which was always discarded. Electrically
evoked contractions were evaluated in the presence of
atropine (2 × 10−6M), guanethidine (5 × 10−6M) and
L-nitro arginine methyl ester (L-NAME 2 × 10−4M), an
inhibitor of NO synthase. The contact time was 30 min
for atropine and guanethidine and 45 min for L-NAME.
The concentration of atropine was chosen on the basis
of previous experiments showing that they fully blocked
the contraction produced by 1 × 10−4M carbachol. The
concentration of guanethidine was chosen on the basis
of literature data [20, 21]. At the end of each experi-
ment, strips were removed, blotted, and weighed.
Chemicals
Carbachol chloride, histamine dihydrochloride, atropine
sulphate, guanethidine sulphate, and L-nitro arginine
methyl ester (L-NAME) were purchased from Sigma
Chemical Co. (St Louis, Missouri, United States). Other
chemicals were of the highest quality and were obtained
from commercial sources.
Statistical analysis
The results are given as means ± standard error (SE)
(n indicates the number of patients). Carbachol- and
histamine-induced contractions were measured as increases
over baseline activity and were calculated as mN per cross
sectional area (expressed in cm2) [18, 19, 22, 23]. We then
expressed concentration-response data as a percentage of
the maximal response to carbachol or histamine and
calculated half-maximal effective concentration (EC50)
values with 95% confidence intervals (CIs) from log
concentration-response curves using non-linear regression
analysis. Stress induced by electrical stimulation was
expressed as mN per cross sectional area [18, 19, 22, 23].
We compared data sets with a paired Wilcoxon test
(responses before and after treatment), unpaired Mann-
Whitney U test (differences between groups), and unpaired
Student’s t test, as appropriate. We used a commercial
statistical package (GraphPad Prism, version 5 for Win-
dows, GraphPad Software, San Diego, California, United
States) and considered statistical significance achieved when
P < 0.05.
Results
Response to carbachol and histamine
In male patients, carbachol (1 × 10−8M-1 × 10−6M) and
histamine (1 × 10−8M-1 × 10−6M) caused concentration-
dependent contractions in circular muscle strips in the
CG and SG (Fig. 1). EC50 values to carbachol were
8.54 × 10−6M (95% CI 4.54–16.0 × 10−6M) and 1.58 ×
10−6M (95% CI 0.68–3.70 × 10−6M) in CG and SG re-
spectively (Fig. 1). This response was greater in SG than
in CG (P < 0.01). Moreover, the maximal responses to
carbachol (expressed in mN/cm2) were significantly
higher in SG male patients (4623.0 ± 894.4 mN/cm2 in
SG vs 1621.0 ± 204.5 mN/cm2 in CG; P < 0.01).
The same was true when we analyzed histamine-induced
responses: EC50 values were 3.77 × 10
−6M (95% CI 1.79–
7.94 × 10−6M) and 0.37 × 10−6M (95% CI 0.09–1.42 ×
10−6M) in CG and SG, respectively. This response was
greater in SG than in CG (P < 0.001) (Fig. 2). Again, the
maximal responses to histamine were significantly higher in
Fig. 1 Log concentration-response curves for carbachol in male and
female patients [control group (CG), study group (SG)]. All responses are
expressed as a percentage of the control maximal response to carbachol.
Results are means ± standard error (SE) (n= 15 male patients and n= 14
female patients). P< 0.01, half-maximal effective concentration (EC50)
value in SG male patients vs CG male patients; P < 0.01, maximal
response in SG male patients vs CG male patients; P< 0.001, maximal
response in CG female patients vs SG female patients
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SG male patients (2895.0 ± 220.0 mN/cm2 in SG vs 847.8 ±
123.9 mN/cm2 in CG; P < 0.001).
Conversely, in female patients, the response to carba-
chol (1 × 10−8M-1 × 10−6M) was not significantly different
in the two groups, with a trend towards a reduced re-
sponse in SG: EC50 values for carbachol were 3.84 ×
10−6M (95% CI 1.85–7.96 × 10−6M) and 6.84 × 10−6M
(95% CI 3.70–12.63 × 10−6M) in CG and SG, respectively
(Fig. 1). The maximal responses to carbachol were signifi-
cantly higher in CG female patients (2247.0 ± 186.9 mN/
cm2 in CG vs 1354.0 ± 109.9 mN/cm2 in SG; P < 0.001).
The response to histamine was not significantly differ-
ent in the two groups, with a trend towards a reduced
response in CG: EC50 values for histamine were 7.99 ×
10−6M (95% CI 4.27–14.97 × 10−6M) and 3.85 × 10−6M
(95% CI 2.07–7.14 × 10−6M) in CG and SG, respectively
(Fig. 2) and the maximal responses to histamine were
not significantly different in the two groups (1384 ±
154.6 mN/cm2 in CG, 1292.0 ± 148.7 mN/cm2 in SG).
Moreover, analyzing groups of different gender, in SG
maximal responses to carbachol and histamine were sig-
nificantly more pronounced in male vs female patients
(P < 0.001) and EC50 values to histamine were signifi-
cantly different in male vs female patients (P < 0.001). In
CG, the maximal response to histamine was significantly
more pronounced in female vs male patients (P < 0.05).
Electrically evoked contractions
In both patient groups, electrically evoked contractions
in circular muscle strips were linearly related to stimula-
tion frequency in the 0.1–10 Hz range: analyzing groups
of different gender, electrically evoked contractions were
significantly more pronounced in male than in female
patients both in CG that in SG at all frequencies.
The contractions in male patients were much more
marked in SG than in CG in the 0.3–10 Hz frequency
range (Fig. 3). The same trend was observed in female
patients, where electrically evoked contractions were
more marked in SG than in CG at frequency 0.1 Hz, 1–
10 Hz (Fig. 3).
Analyzing groups of different gender, electrically
evoked contractions were significantly more pronounced
in male than in female patients both in CG that in SG at
all frequencies. In male patients, atropine and guanethi-
dine per se inhibited electrically evoked contractions de-
pending on stimulation frequency. The inhibition was
significant in CG at all frequencies and in SG only at 3–
10 Hz. The addition of L-NAME reversed atropine and
guanethidine inhibition, increasing electrically evoked
responses at all frequency in CG and in SG only at 1–
3 Hz (Fig. 4a-b).
In females, also atropine and guanetidine inhibited elec-
trically evoked contractions in CG at all frequency while
in SG at the frequency 0.3–10 Hz. As in male patients, the
addition of L-NAME reversed atropine and guanetidine
inhibition increasing electrically evoked responses in CG
Fig. 2 Log concentration-response curves for histamine in male and
female patients [control group (CG), study group (SG)]. All responses
are expressed as a percentage of the control maximal response to
histamine. Results are means ± standard error (SE) (n = 15 male
patients and n = 14 female patients). P < 0.001, half-maximal effective
concentration (EC50) value in SG male patients vs CG male patients; P
< 0.001, EC50 value in SG male patients vs SG female patients; P < 0.001,
maximal response in SG male patients vs CG male patients; P < 0.001,
maximal response in SG male patients vs SG female patients; P < 0.05,
maximal response in CG female patients vs CG male patients
Fig. 3 Electrically evoked contractions related to stimulation
frequency (range: 0.1–10 Hz) in male and female patients [control
group (CG), study group (SG)]. Results are means ± standard error
(SE) (n = 8 male CG, n = 7 male SG, n = 7 female CG, n = 7 female
SG). aP < 0.05 and bP < 0.01, CG male patients vs SG male patients;
cP < 0.05 and dP < 0.01, CG female patients vs SG female patients; eP
< 0.01 and fP < 0.001, CG male patients vs CG female patients; gP <
0.05, hP < 0.01 and iP < 0.001, SG male patients vs SG female patients
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and in SG, but this was significant at all frequencies only
in CG (Fig. 5a-b).
Notably, the effect of L-NAME was most marked in
CG males and less pronounced in SG males, CG and SG
females.
Discussion
In this study, in vitro colonic motor responses to carba-
chol, histamine or electrical stimulation after chemo-
and radiotherapy were quite different in male and female
patients. Some of the observed gender differences were
so remarkable that in our opinion they deserve a prelim-
inary report here, since they are also in line with circum-
stantial evidence already available in the literature.
However, we must acknowledge important intrinsic limi-
tations of our study: we could analyse only a limited
number of surgical specimens, which did not allow us to
further investigate mechanisms underlying the gender
differences. Furthermore, we cannot completely rule out
the possibility that at least some of the observed differ-
ences might be due to heterogeneity of the clinical con-
dition in individual patients.
Colonic circular muscle strips after chemo- and radio-
therapy in SG were more sensitive to carbachol and hista-
mine with respect to controls in males. Sensitivity to
carbachol in these patients is in line with previous findings
showing hypercontractility in gastric fundic and duodenal
muscle, in both inflammatory and post-inflammatory
phases of 5-FU induced intestinal mucositis in rats [4].
Other authors showed increased sensitivity to cholinergic
stimulation in the duodenum and colon after whole-body
irradiation in guinea pigs [5]. This increased responsive-
ness may be associated with colonic motor alterations
consisting in giant contractions in dogs and intestinal
migrating motor complexes disruption in rats [2, 6]. The
increased incidence of giant contractions has been
Fig. 4 Electrically evoked contractions in control group (CG) (a) and study group (SG) (b) male patients. CG and SG experiments in the presence of
atropine and guanethidine or atropine, guanethidine, and L-nitro arginine methyl ester (L-NAME). Results are means ± standard error (SE); a, n = 8
patients; b, n = 7 patients. aP < 0.05, bP < 0.01 and cP < 0.001, atropine and guanethidine vs controls; dP < 0.05 and eP < 0.01, atropine and guanethidine
vs atropine, guanethidine, and L-NAME
Fig. 5 Electrically evoked contractions in control group (CG) (a) and study group (SG) (b) female patients. CG and SG experiments in the presence of
atropine and guanethidine or atropine, guanethidine, and L-NAME. Results are means ± standard error (SE); a, n = 7 patients, b, n = 7 patients. aP < 0.05
and bP < 0.01, atropine and guanethidine vs controls; cP < 0.05, atropine and guanethidine vs atropine, guanethidine, and L-NAME
Maselli et al. BMC Pharmacology and Toxicology  (2018) 19:49 Page 5 of 8
suggested to be responsible for the iatrogenic side ef-
fects such as diarrhea, abdominal cramping and vomiting
[2, 6, 24]. Furthermore, other studies have demonstrated
significant enhancement in gastrointestinal muscle con-
tractility in response to carbachol during chronic inflam-
mation and infections [8, 9]. When the mucosal barrier is
damaged, the use of chemo- and radiotherapy represents
a risk factor for local infections and sepsis [7].
Increased sensitivity to histamine has also been reported
in inflammatory conditions related to the release of leuko-
trienes enhancing histamine receptor numbers [10].
Nevertheless, this increased sensitivity to contractile
agonists is somewhat controversial. Sung et al. showed
significantly reduced contractility to carbachol in human
stomach after cisplatin-based chemotherapy [13]. Besides,
the response to histamine did not change in colitis in rats
[14]. These discrepancies might be related to differences
in species, intestinal tracts, duration of chemotherapy or
length of time after chemotherapy as well as to gender.
In the present study, the sensitivity and the maximum
response to carbachol or histamine were greater in male
than in female SG patients. Even considering the mean
age of our patients, this different response might at least
in part be ascribed to female hormones, although we
cannot rule out other factors. Indeed, Kaur et al. [25]
showed increased estrogen levels after surgery even in
postmenopausal women. This may be an indicator than
under stress (as after chemo- and radiotherapy) estrogen
levels can be higher even in postmenopausal women.
Therefore the different responses that we observed
might be relative to an effect of female hormones still re-
leased under stress. An alternative explanation is that
gender differences might be ascribed to the fact that in
postmenopausal women tissues, in any case, have been
exposed to estrogens in previous years, so that, even
when oestrogen levels decrease, tissue responses may
still differ. Interestingly, ovariectomy in adult female rab-
bits caused altered receptor sensitivity and increased in-
trinsic smooth muscle sensitivity to histamine in vascular
smooth muscle. This would further explain the gender-
dependent difference that we observed in females com-
pared to males [26].
In the CG, we confirm the data previously published
in our recent study on elderly female and male patients,
where females were more sensitive and showed higher
maximal response to carbachol [17]. These observations
are in line with previous findings, one showing increased
response to carbachol in animals, while the other sug-
gested that aging induces an increase in Calcium ions
(Ca2+) store with consequent Ca2+ overload, although
these data do not specifically refer to gender differences
[27, 28].
Also electrically evoked contractions were more
marked in SG than in CG in both genders and this may
be due to the formation of peroxynitrite. During severe
inflammation, as observed after 5-FU treatment, a gener-
ation of reactive oxygen species (ROS) occurs. ROS dir-
ectly damage cells, tissues, blood vessels and stimulate
transcriptions factors, such as nuclear transcription
factor-kB (NF-kB), which in turn causes up-regulation of
pro-inflammatory cytokines, such as interleukin-1(IL-1),
interleukin-6 (IL-6) and tumor necrosis factor alpha
(TNF-alfa). Previous reports show that 5-FU induces
oral mucositis causing proinflammatory cytokines that
stimulate iNOS-derived NO production [7]. The reac-
tion between NO and ROS produces peroxynitrite, a
toxic compound that causes lipid peroxidation, oxidation
of protein sulfhydryl groups, with tissue injury and local
increase of inflammation [7, 29, 30].The increased elec-
trically evoked contraction could also be attributed to
tachykininergic components. The increase in gastro-
intestinal transit occurring during infection is mediated
by endogenous tachykinins, which are modulated by the
activation of NO biosynthesis [11]. This tachykininergic
component is most probably expressed in elderly male
patients. In fact, Burcher et al. showed a gender-related
difference in receptor density of human colon, with
binding capacity (Bmax) lower in females than in males
[12]. An increase in NO is in agreement with reports of
an increased plasma nitric oxide after oral administra-
tion of anticancer drugs in rats and in disagreement with
other reports of a reduced expression of the inducible
form of NOS in rats receiving cisplatin and of no change
in neural NO synthase (nNOS) expression in patients re-
ceiving chemotherapy [13, 15, 16].
It is difficult to explain why the electrically evoked
contractile response were greater in males than in fe-
males after chemo- and radiotherapy. However, even in
the control group, the response to electrical stimulation
is greater in males than in females, as we have already
shown in previous work [17]. Besides, the response to
EFS and L-NAME was lower in females than in males
both in CG and in SG, possibly because elderly females
are not under the influence of female hormones unlike
adult females, as suggested in our previous study [17].
One study hypothesized that advanced age is associ-
ated with decreased expression of neuronal NO syn-
thase (nNOS) and concomitant reduction in synthesis
of NO in rat colon [31]. That may contribute to explain
our findings in females. Other studies showed that estro-
gens increase endothelial NO synthase (eNOS) [32, 33], but
inhibit iNOS [32]. During inflammatory reactions, NO
levels, produced by iNOS, increase and this may contribute
to local tissue damage [34–37]. This may explain the lack
of difference in response to L-NAME group SG in both
genders.
In order to explain the increased sensitivity to carbachol
and decreased response to EFS and L-NAME in CG female
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patients we hypothesize a decreased expression of nNOS
with concomitant reduction in synthesis of NO [31].
Conclusions
This preliminary in vitro study indicates gender differ-
ences in the motor responses of colonic circular muscle
strips exposed to cholinergic, histaminergic and electrical
stimulation in patients who have received chemotherapy
with capecitabine and radiotherapy. Further studies to elu-
cidate the underlying mechanisms are warranted.
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